Condition

Axial Spondyloarthritis

ClinicalTrials.gov condition label

Clinical trials20
Recruiting1
Common interventions20
Lead sponsors shown15

Clinical trials

20 shown
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic DiseasesNCT07087912 · 2026-03-16
RECRUITING
A Study of SPY072 in Rheumatic DiseaseNCT07148414 · 2025-08-21
ACTIVE_NOT_RECRUITING
INSELMA - a Randomised Controlled TrialNCT06583980 · 2024-09-05
ACTIVE_NOT_RECRUITING
Barriers and Faciliators for Physical Activity in People With RMDsNCT06514443 · 2024-08-01
UNKNOWN
WORK-ON Vocational Rehabilitation for People With Inflammatory ArthritisNCT06299917 · 2024-03-01
ACTIVE_NOT_RECRUITING
Enthesis Differences in Rheumatoid Arthritis and Axial SpondyloarthropathyNCT05942976 · 2023-06-16
COMPLETED
The Relationship Between Inflammatory ARTritis and CArdiac DIseAseNCT05647577 · 2021-01-01
ACTIVE_NOT_RECRUITING
The Role of Microbiome on Biological Therapy Efficacy in axSpA and RANCT04973787 · 2020-08-01
UNKNOWN
A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)NCT04163016 · 2020-06-19
COMPLETED
Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in EuropeNCT04397237 · 2020-06-10
UNKNOWN
COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic DiseasesNCT04335747 · 2020-04-23
TERMINATED
PROM Collected Via a Smartphone App Versus a Touch Screen Solution Among Patients With Inflammatory ArthritisNCT03486613 · 2019-04-24
COMPLETED
Rheumatism and Dietetic: RHUMADIET Study (Food Practices and Beliefs)NCT03770884 · 2019-01-08
COMPLETED
Lessening the Impact of Fatigue in Inflammatory Rheumatic DiseasesNCT03248518 · 2017-09-05
COMPLETED
Observational Study to Evaluate the Real-Life Effectiveness of Benepali Following Transition From EnbrelNCT03100734 · 2017-06-01
COMPLETED
Patient Reported Outcomes Reported Via PC / Tablet Home Versus Touch Screen at Hospital Among Patients With ArthritisNCT02818478 · 2016-05-01
COMPLETED
Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic DiseasesNCT03214263 · 2015-05-01
UNKNOWN
PatientSpot Formerly Known as ArthritisPowerNCT03840928 · 2015-04-01
UNKNOWN
A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.NCT02486302 · 2015-03-24
COMPLETED
Expanded Access to UpadacitinibNCT04159597
AVAILABLE

Common interventions

BenepaliBIOLOGICAL1biological disease-modifying antirheumatic drugs (bDMARDs)BIOLOGICAL1Cognitive behavioural approachBEHAVIORAL1COVID-19 infectionOTHER1Dengue 1,2,3,4 (attenuated) vaccineBIOLOGICAL1EnbrelBIOLOGICAL1EtanerceptDRUG1Interdisciplinary Nurse-coordinated self-management support for people with inflammatory arthritis and substantial disease impactBEHAVIORAL1Personalised Exercise ProgrammeBEHAVIORAL1Pharmacokinetics of certolizumab pegolDRUG1PlaceboDRUG1PROM registration via the DANBIO App on a smartphoneOTHER1PROM registration via the touch screen solutionOTHER1Reporting of patient reported outcome measuresOTHER1SPY002-072DRUG1surveyOTHER1ULTRASOUNDOTHER1UpadacitinibDRUG1Usual CareBEHAVIORAL1WORK-ONOTHER1

Trial status mix

COMPLETED8
UNKNOWN5
ACTIVE_NOT_RECRUITING4
AVAILABLE1
RECRUITING1
TERMINATED1

Phase mix

NA5
PHASE11
PHASE21
PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.